Back to FDA Applications sponsored by LANNETT HOLDINGS INC

FDA Drug Application 203823 by LANNETT HOLDINGS INC

Application Number203823
Application Type Abbreviated New Drug Application
Sponsor ApplicantLANNETT HOLDINGS INC
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type
Therapeutic Potential
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP08/1/2014N40124000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203823Orig1s000ltr.pdf 8/4/2014




Back to FDA Applications sponsored by LANNETT HOLDINGS INC